The Concept of Figure of Merit Applied to Protection System Coordination

Autor: J. A. Juves, R. W. Johnson, S. S. Waters, E. J. Mayer

Publikováno v: IEEE Power Engineering Review. :25-26

Clearly there is a need for further development and discussion of the Figure of Merit concept. This paper has presented three alternative Figures of Merit with numerical examples for a sample power system. The need for these measuring parameters is c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96dbd6e1a3f29567b1ce4df1aa3c4544
https://doi.org/10.1109/mper.1986.5527592

A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial.

Autor: Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: ghortoba@mdanderson.org., Lacko A; Dolnoslaskie Centrum Onkologii, Wroclaw, Poland., Sohn J; Severance Hospital, Seoul, Korea., Cruz F; Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil., Ruiz Borrego M; Hospital Virgen del Rocio de Sevilla, Seville, Spain., Manikhas A; Saint Petersburg City Clinical Oncology Dispensary, Saint Petersburg, Russia., Hee Park Y; Samsung Medical Center, Seoul, Korea., Stroyakovskiy D; Moscow City Oncology Hospital No. 62 of Moscow Healthcare Department, Moscow, Russia., Yardley DA; Sarah Cannon Research Institute, Nashville, USA., Huang CS; National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei City, Taiwan., Fasching PA; University Hospital Erlangen Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Crown J; St Vincent's Private Hospital, Dublin, Ireland., Bardia A; David Geffen School of Medicine at UCLA, Los Angeles, USA., Chia S; BC Cancer - Vancouver, Vancouver, Canada., Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid, Spain., Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China., Hurvitz S; University of Washington, Fred Hutchinson Cancer Center, Seattle, USA., Barrios C; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Untch M; Interdisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin, Germany., Moroose R; Orlando Health Cancer Institute, Orlando., Visco F; National Breast Cancer Coalition, Washington, USA., Parnizari F; TRIO - Translational Research in Oncology, Montevideo, Uruguay., Zarate JP; Novartis Pharmaceuticals Corporation, East Hanover, USA., Li Z; Novartis Pharmaceuticals Corporation, East Hanover, USA., Waters S; Novartis Ireland, Dublin, Ireland., Chakravartty A; Novartis Pharmaceuticals Corporation, East Hanover, USA., Slamon D; David Geffen School of Medicine at UCLA, Los Angeles, USA.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Oct 21. Date of Electronic Publication: 2024 Oct 21.

Correction to: The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age‑matched controls.

Autor: Lawn W; Clinical Psychopharmacology Unit, University College London, London, UK. will.lawn@kcl.ac.uk.; Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. will.lawn@kcl.ac.uk.; Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. will.lawn@kcl.ac.uk., Fernandez-Vinson N; Clinical Psychopharmacology Unit, University College London, London, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Mokrysz C; Clinical Psychopharmacology Unit, University College London, London, UK., Hogg G; Clinical Psychopharmacology Unit, University College London, London, UK., Lees R; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK., Trinci K; Clinical Psychopharmacology Unit, University College London, London, UK., Petrilli K; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK., Borissova A; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; NIHR University College London Hospitals Biomedical Research Centre, University College Hospital, London, UK., Ofori S; Clinical Psychopharmacology Unit, University College London, London, UK., Waters S; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK., Michór P; School of Life Sciences, University of Warwick, Coventry, UK., Wall MB; Clinical Psychopharmacology Unit, University College London, London, UK.; Invicro London, Hammersmith Hospital, Burlington Danes Building, Du Cane Road, London, UK., Freeman TP; Clinical Psychopharmacology Unit, University College London, London, UK.; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK., Curran HV; Clinical Psychopharmacology Unit, University College London, London, UK.

Publikováno v: Psychopharmacology [Psychopharmacology (Berl)] 2022 Jul; Vol. 239 (7), pp. 2371.

Identification of functional candidate variants and genes for feed efficiency in Holstein and Jersey cattle breeds using RNA-sequencing.

Autor: Lam S; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1., Miglior F; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1., Fonseca PAS; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1., Gómez-Redondo I; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1., Zeidan J; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1., Suárez-Vega A; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1., Schenkel F; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1., Guan LL; Department of Agriculture, Food & Nutritional Science, University of Alberta, Edmonton, Canada T6H 2P5., Waters S; Teagasc, Animal & Grassland Research and Innovation Centre, Grange, Dunsany, Ireland C15 PW93., Stothard P; Department of Agriculture, Food & Nutritional Science, University of Alberta, Edmonton, Canada T6H 2P5., Cánovas A; Centre for Genetic Improvement of Livestock, Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1. Electronic address: acanovas@uoguelph.ca.

Publikováno v: Journal of dairy science [J Dairy Sci] 2021 Feb; Vol. 104 (2), pp. 1928-1950. Date of Electronic Publication: 2020 Dec 23.

(3 S )-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.

Autor: Hjorth S; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.) clas.sonesson@irlab.se stephan.hjorth@irlab.se., Waters S; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Waters N; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Tedroff J; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Svensson P; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Fagerberg A; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Edling M; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Svanberg B; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Ljung E; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Gunnergren J; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., McLean SL; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Grayson B; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Idris NF; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Neill JC; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.)., Sonesson C; Integrative Research Laboratories Sweden AB (IRL AB), Gothenburg, Sweden (S.H., S.W., N.W., J.T., P.S., A.F., M.E., B.S., E.L., J.G., C.S.); Pharmacilitator AB, Vallda, Sweden (S.H.); Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.); School of Pharmacy and Medical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom (S.L.M.); and Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom (B.G., N.F.I., J.C.N.) clas.sonesson@irlab.se stephan.hjorth@irlab.se.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2020 Sep; Vol. 374 (3), pp. 404-419. Date of Electronic Publication: 2020 Jun 30.